The influence of food on the pharmacokinetics of piperaquine in healthy Vietnamese volunteers

Acta Tropica

Volumn 107, Issue 2, 2008, Pages 145-149

  Hai, Trinh Ngoc ^a   Hietala, Sofia Friberg ^b   Van Huong, Nguyen ^a   Ashton, Michael ^b  

^a National Institute of Malariology Parasitology and Entomology Hanoi   (Viet Nam)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Food drug interactions; Malaria; Pharmacokinetics; Piperaquine

Indexed keywords

ARTECAN; DIHYDROARTEMISININ PLUS PIPERAQUINE; PIPERAQUINE;

DRUG; ESTIMATION METHOD; FOOD; MALARIA; PROTOZOAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FOOD; FOOD DRUG INTERACTION; HUMAN; MALARIA FALCIPARUM; MALE; MEAL; NORMAL HUMAN; RANDOMIZATION; SINGLE DRUG DOSE; VIET NAM;

ADMINISTRATION, ORAL; ADULT; ANTIMALARIALS; AREA UNDER CURVE; ARTEMISININS; BIOLOGICAL AVAILABILITY; DRUG THERAPY, COMBINATION; FASTING; FEMALE; FOOD-DRUG INTERACTIONS; HUMANS; MALE; MEAT; MIDDLE AGED; OVUM; QUINOLINES; VEGETABLES; VIETNAM; VOLUNTARY WORKERS;

ASIA; EURASIA; SOUTHEAST ASIA; VIET NAM;

EID: 47549100818     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2008.05.013     Document Type: Article

References (22)

1. Ahmed T., Sharma P., Gautam A., Varshney B., Kothari M., Ganguly S., Moehrle J.J., Paliwal J., Saha N., and Batra V. Safety, tolerability, and single- and multiple-dose pharmacokinetics of piperaquine phosphate in healthy subjects. J. Clin. Pharmacol. 48 (2008) 166-175
2. Ashley E.A., McGready R., Hutagalung R., Phaiphun L., Slight T., Proux S., Thwai K.L., Barends M., Looareesuwan S., White N.J., and Nosten F. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clin. Infect. Dis. 41 (2005) 425-432
3. Denis M.B., Davis T.M., Hewitt S., Incardona S., Nimol K., Fandeur T., Poravuth Y., Lim C., and Socheat D. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin. Infect. Dis. 35 (2002) 1469-1476
4. Hasugian A.R., Purba H.L., Kenangalem E., Wuwung R.M., Ebsworth E.P., Maristela R., Penttinen P.M., Laihad F., Anstey N.M., Tjitra E., and Price R.N. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clin. Infect. Dis. 44 (2007) 1067-1074
5. Hung T.Y., Davis T.M., Ilett K.F., Karunajeewa H., Hewitt S., Denis M.B., Lim C., and Socheat D. Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria. Br. J. Clin. Pharmacol. 57 (2004) 253-262
6. Karunajeewa H., Lim C., Hung T.Y., Ilett K.F., Denis M.B., Socheat D., and Davis T.M. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. Br. J. Clin. Pharmacol. 57 (2004) 93-99
7. Karunajeewa H.A., Ilett K.F., Mueller I., Siba P., Law I., Page-Sharp M., Lin E., Lammey J., Batty K.T., and Davis T.M. Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. Antimicrob. Agents Chemother. 52 (2008) 237-243
8. Lindegardh N., White N.J., and Day N.P. High throughput assay for the determination of piperaquine in plasma. J. Pharm. Biomed. Anal. 39 (2005) 601-605
9. Liu C., Zhang R., Hong X., Huang T., Mi S., and Wang N. Pharmacokinetics of piperaquine after single and multiple oral administrations in healthy volunteers. Yakugaku Zasshi 127 (2007) 1709-1714
10. Mayxay M., Thongpraseuth V., Khanthavong M., Lindegardh N., Barends M., Keola S., Pongvongsa T., Phompida S., Phetsouvanh R., Stepniewska K., White N.J., and Newton P.N. An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos). Trop. Med. Int. Health 11 (2006) 1157-1165
11. Ratcliff A., Siswantoro H., Kenangalem E., Maristela R., Wuwung R.M., Laihad F., Ebsworth E.P., Anstey N.M., Tjitra E., and Price R.N. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet 369 (2007) 757-765
12. Roshammar D., Hai T.N., Friberg Hietala S., Van Huong N., and Ashton M. Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects. Eur. J. Clin. Pharmacol. 62 (2006) 335-341
13. Sim I.K., Davis T.M., and Ilett K.F. Effects of a high-fat meal on the relative oral bioavailability of piperaquine. Antimicrob. Agents Chemother. 49 (2005) 2407-2411
14. Smithuis F., Kyaw M.K., Phe O., Aye K.Z., Htet L., Barends M., Lindegardh N., Singtoroj T., Ashley E., Lwin S., Stepniewska K., and White N.J. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Lancet 367 (2006) 2075-2085
15. Tangpukdee N., Krudsood S., Thanachartwet W., Chalermrut K., Pengruksa C., Srivilairit S., Silachamroon U., Wilairatana P., Phongtananant S., Kano S., and Looareesuwan S. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Southeast Asian J. Trop. Med. Public Health 36 (2005) 1085-1091
16. Tarning J., Ashley E.A., Lindegardh N., Stepniewska K., Phaiphun L., Day N.P., McGready R., Ashton M., Nosten F., and White N.J. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand. Antimicrob. Agents Chemother. 52 (2008) 1052-1061
17. Tarning J., Lindegardh N., Annerberg A., Singtoroj T., Day N.P., Ashton M., and White N.J. Pitfalls in estimating piperaquine elimination. Antimicrob. Agents Chemother. 49 (2005) 5127-5128
18. Tarning J., Lindegardh N., Sandberg S., Day N.J., White N.J., and Ashton M. Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat. J. Pharm. Sci. (2007) 10.1002/jps.21226
19. Thang N.M., and Popkin B.M. Patterns of food consumption in Vietnam: effects on socioeconomic groups during an era of economic growth. Eur. J. Clin. Nutr. 58 (2004) 145-153
20. Tran T.H., Dolecek C., Pham P.M., Nguyen T.D., Nguyen T.T., Le H.T., Dong T.H., Tran T.T., Stepniewska K., White N.J., and Farrar J. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet 363 (2004) 18-22
21. U.S. Department of Health and Human Services Food and Drug Administration/Center for Drug Evaluation and Research (CDER), 2003. Guidance for Industry. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations. http://www.fda.gov/cder/guidance/5356fnl.pdf (accessed on May 15, 2008).
22. Warhurst D.C., Craig J.C., Adagu I.S., Guy R.K., Madrid P.B., and Fivelman Q.L. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases. Biochem. Pharmacol. 73 (2007) 1910-1926